Viracta Therapeutics Inc (VIRX)

Finanzdaten der Viracta Therapeutics Inc-Aktie (VIRX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	2.32% 13.88	13.56	12.47	12.45	12.21
Interest Income/Expense	9.59% 0.858	0.949	0.953	0.921	0.88
Operating Income/Loss	2.32% -13.88	-13.56	-12.47	-12.45	-12.21
Income/Loss From Continuing Operations Before Tax	33.59% -9.141	-13.77	-12.60	-12.48	-12.21
Income/Loss From Continuing Operations After Tax	33.59% -9.141	-13.77	-12.60	-12.48	-12.21
Net Income/Loss	33.59% -9.141	-13.77	-12.60	-12.48	-12.21
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	70,188% 39.32	0.0559	38.68	38.56	38.46
Diluted Average Shares	70,188% 39.32	0.0559	38.68	38.56	38.46
Basic Earnings Per Share	34.29% -0.23	-0.35	-0.33	-0.32	-0.32
Diluted Earnings Per Share	34.29% -0.23	-0.35	-0.33	-0.32	-0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-